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Abstract: Salvia plants belong to the Lamiaceae family and are recognized as being strongly aromatic,
being widely used for different purposes in culinary or traditional medicine. These plants are
well recognized as being rich in phenolic acids, flavonoids and terpenic compounds, which exhibit
health-beneficial activities, protecting against oxidative and inflammatory-related diseases, such as
diabetes and obesity. Because of these properties, phytochemicals from Salvia species have been
investigated as health promoting agents, for application in distinct fields. However, the growing
demand for natural products with possible uses and applications in industry requires scientific
validation studies. This review consists of a compilation of relevant studies with an emphasis on the
antioxidant, antidiabetic and anti-obesity properties of phenolic-rich extracts from Salvia plants.
Keywords: Salvia; polar extracts; phenolic compounds; antioxidant; antidiabetic; anti-obesity
1. Introduction
There is a clear trend in consumer preference towards natural food ingredients and
additives that are perceived to be healthy [1]. It is well known that diet supplementation
with plant-based products rich in phytochemicals, like phenolic compounds [2,3], can
provide a positive influence on human health—reducing the risk of cancer, diabetes and
inflammatory diseases, and preventing neurodegenerative and cardiovascular system
disorders, among others [4–6]. In this context, knowledge of the bioactive potential of
unexplored plant secondary metabolites may grant the development of new plant-based
functional foods, nutraceuticals and drugs [6,7].
Salvia is the largest genus in the Lamiaceae family of plants, with over 900 species [8].
The name Salvia has its origin in the Latin word salvare, that means “healer”, in reference
to the curative properties of these plants, which have been used since ancient times as
a medicinal herb [9,10]. The plants of this genus are distributed worldwide, although
they are particularly prevalent in tropical and temperate regions of Europe around the
Mediterranean area, in South-East Asia and in Central and South America [8,11]. They
are mostly aromatic and perennial shrubs, with flowers of distinct colors (e.g., violet, blue,
lilac or pale-blue), size and structure—such as their staminal lever, the length and form of
the corolla tube and their floral nectary morphology. In general, stems are long, reaching
between 50 to 100 cm, with 3 to 5 branches, containing opposite, simple, ovate and petiolate
leaves [12–14].
Sage plants have been used for centuries in culinary, cosmetic and fragrance industries,
and in traditional medicine [9,10,15]. The latter application includes their use in a wide
range of ailments, including digestive, respiratory, renal, hepatic, neurological, cardiac,
blood circulation and metabolic, among others [16–19]. In fact, many authors confirmed the
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potential bioactive properties of Salvia constituents, such as those in essential oils [20–23].
More recently, polar extracts rich in phenolic compounds have also emerged as promising
bioactive agents, enabling them to be applied in different areas [15,24–27].
This review highlights the health benefits of several Salvia species as potential sources
of phenolic compounds that can combat oxidative stress and related diseases, namely
diabetes and obesity. The summary of relevant studies focusing on these issues is shown in
the four tables of this manuscript which also include the available information regarding
the main phenolic constituents.
1.1. Antioxidant Activity
Oxidative stress results from an imbalance condition between generation and elimi-
nation of reactive oxygen species (ROS), including superoxide (O2•−), hydroxyl radicals
(•OH) and hydrogen peroxide (H2O2), together with reactive nitrogen species (RNS) such
as nitric oxide (NO•) and peroxynitrite (ONOO−), which cause severe damage to cellular
components such as DNA, proteins and lipids—contributing to the pathogenesis of many
diseases [3,28,29]. In turn, enzymatic ((e.g. catalase (CAT), superoxide dismutase (SOD),
glutathione peroxidase (GPx) and glutathione-S-transferase (GST)) and non-enzymatic
((e.g. vitamins A, C and E, reduced glutathione (GSH), β-carotene)) antioxidants counteract
oxidative stress [3,29–31]. In this regard, a growing body of evidence suggests that diet sup-
plementation with antioxidant compounds, through a daily consumption of plant-based
products, can provide an important tool to counteract the adverse effects of oxidative stress
and related diseases [2,3,32,33]. Having this in mind, the gathering of scientific data to
corroborate the traditional usage of these plants is a key step in promoting their industrial
application [2,6,34–36].
1.1.1. Antioxidant Activity of Salvia Extracts—Chemical Models
As for plants in general, the antioxidant potential of sage extracts has been evaluated
as a first approach through in vitro methods (Table 1), including the capacity to scavenge
stable free radicals such as DPPH• (2.2-diphenyl-1-picrylhydrazyl), ABTS• (2.2’-azino-bis-
3-ethylbenzthiazoline-6-sulphonic acid), hydroxyl (•OH), superoxide (O2•−) and nitric
oxide (NO•), and also by the ability to reduce metal ions from their higher to their lower
oxidation state by the reducing power method (RP) and ferric reducing antioxidant power
assay (FRAP). Additional assays include the oxygen radical absorbance capacity (ORAC),
for assessing radical chain-breaking ability through the inhibition of peroxyl radical (RO2•)–
induced oxidation, and the trolox equivalence antioxidant capacity (TEAC), as well as
the thiobarbituric acid reactive substances (TBARS) and β-carotene bleaching assays, to
estimate the lipid peroxidation inhibitory capacity [24,37,38].
Among sage plants, S. officinalis is the most widespread worldwide and also the most
studied regarding antioxidant capacity [24,39]. Due to their high antioxidant capacity,
S. officinalis polar phenolic extracts, usually alcoholic or hydroalcoholic extracts, are also
frequently used as a reference to assess antioxidant properties of other less investigated
plants [40,41]. The DPPH EC50 values (half maximal effective concentration, equivalent
to the sample concentration that provides 50% of antioxidant activity) of distinct extracts
from this species were established in the range of 1.98–10.1 µg/mL [41–43], being close to
that of the flavonol quercetin (2.79 µg/mL) [44]. The antioxidant activity of S. officinalis
phenolic-rich extracts has also been extensively assessed by the ABTS• scavenging assay
(EC50 = 4.79–50.8 µg/mL) [43,44], through evaluation of the ability to scavenge superox-
ide (EC50 = 5.3–10.1 µg/mL) [42] and hydroxyl radicals (EC50 = 1.36 µg/mL) [43], and
also by the ORAC assay (0.4–1.8 mmol TE/100 mL) [45]. Moreover, methanolic extracts
and decoctions of S. officinalis were shown to exhibit very low EC50 values, as estimated
by ß-carotene bleaching (EC50 = 6.6 and 50.9 µg/mL, respectively) and TBARS assays
(EC50 = 2.1 and 10.4 µg/mL, respectively) [46]. More recently, Soxhlet extraction of S. offici-
nalis provided samples with high antiradical activity, with respective DPPH• and ABTS•
EC50 values of 116.5 and 88.2 µg/mL for aqueous extract, and 124.7 and 99.3 µg/mL for
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the hydroethanolic extract. Additionally, the authors showed that extracts obtained with a
Soxhlet or by traditional methods presented a similar antioxidant activity against RO2•
(EC50 values of 0.52 and 0.61 µg/mL for hydroethanolic and aqueous soxhlet extraction ver-
sus 0.52 and 0.69 µg/mL for hydroethanolic maceration and infusion traditional extraction,
respectively) [47].
As for other Salvia species, methanolic extracts of Salvia from Tunisia origin (Salvia aegyptiaca,
Salvia argentea and Salvia verbenaca), were reported to scavenge DPPH•
(EC50 = 21–77 µg/mL) and ABTS• (141–318µM TE/mg DW), as well as to reduce the ferric form
(81–164 mM Fe(II)/mg DW) [41]. Moreover, the DPPH EC50 values of methanol:chloroform (1:1)
extracts of 14 Salvia plants from South Africa, which in general contained rosmarinic acid as
their major phenolic constituent, were shown to vary between 1.6 µg/mL (Salvia schlechteri)
and 74.2 µg/mL (Salvia garipensis) [48]. In the same line, polar extracts of Salvia amplex-
icaulis [49] and Salvia ringens [50], both rich in kaempferol glycosides (298 to 636 mg/g
extract and 120 to 465 mg/g extract, respectively), were suggested as good antioxidant
agents, as estimated by DPPH•, ABTS• and FRAP methods. Moreover, a methanolic extract
of Salvia syriaca, with considerable amounts of rutin and rosmarinic acid, displayed a
high DPPH• scavenging activity, with the same magnitude of the standard solution 3.5-
di-tert-butyl-4-hydroxytoluene (BHT; EC50 values of 70 and 66 µg/mL, respectively) [51].
In addition, phenolic-rich extracts from different populations of Salvia fruticosa [52] and
aqueous and methanolic extracts of Salvia cadmica from Turkey [53], were demonstrated to
scavenge DPPH• and ABTS•, and to reduce ferric ion as well. In these studies, rosmarinic
acid was detected as the main compound, ranging from 20.6 to 41.9 mg/g extract [53].
In good agreement with these results, other Salvia polar extracts, such as S. amplexi-
caulis [49], Salvia halophila [54], Salvia virgata, Salvia persica, Salvia cereal and Salvia reuter-
ana [40], were shown to inhibit β-carotene bleaching, in some cases with equal capacity
to those of the standard compounds. Similarly, the potential of Salvia species to inhibit
lipid peroxidation, as estimated by TBARS assay, was reported for an ethyl acetate extract
of S. halophila, which exerted an inhibitory ability similar to the commercial antioxidant
BHT [54]. Moreover, among five solvent extracts from the aerial parts of Salvia pachy-
phylla, the ethyl acetate extract was the most active based on DPPH• scavenging assay
(EC50 = 0.28 mg/ml) [55]. In addition, Asadi et al [56] reported the scavenging ability of six
Salvia species methanolic extracts as varying between 1 to 487.1 mg ascorbic acid equivalent
/g dried extract, in the order: Salvia hydrangea, Salvia macilenta > Salvia multicalis, Salvia
sclarea > Salvia xanthocheila and Salvia lachnocalyx [56]. Moreover, Kostic et al. [57] reported
good antioxidant ability of ethanolic extracts of S. sclarea, as estimated through DPPH•
(EC50 = 27.8 µg/mL) and inhibition of ß-carotene (EC50 = 19.1 µg/mL) methods. Likewise,
methanolic extracts of S. syriaca and Salvia nemorosa collected in Iran were shown to possess
a scavenging ability towards DPPH• similar to that of BHT [51,58]. The authors found a
good correlation between total phenolic compounds (TPC) and flavonoids (TFC), and their
antioxidant activities, highlighting their richness in rosmarinic acid as well as quercetin
and its glycosides. Other methanolic extracts of a collection of Salvia species, including
Salvia eremophila, Salvia santolinifolia, S. nemorosa and Salvia atropatana, were demonstrated
to be good DPPH• scavengers as well [16], and those of S. sclarea and S. nemorosa were even
claimed to be 1.4–2.2 times lower than those of BHT [40]. The high antioxidant potential of
the two latter extracts was also attested to by other chemical in vitro tests, namely ORAC
and ABTS [59].
Although less studied, aqueous extracts obtained from Salvia plants have also been
reported to be promising antioxidant agents. In this regard, an S. officinalis decoction extract,
rich in quinic acid, protocatechuic acid, gallic acid and salvianolic acid, was shown to inhibit
β-carotene bleaching with IC50 values 2.7-fold higher than BHT [60]. In another study, our
group demonstrated that the decoctions of Salvia africana, Salvia officinalis ‘Icterina’, Salvia
mexicana [26] and Salvia elegans [27], had DPPH• EC50 values in the range of 6.6 ± 0.7 and
10.7± 2.1 µg/mL, with a potency of about half or the same order of ascorbic acid. Likewise,
decoctions of S. africana, S. officinalis ‘Icterina’ and S. mexicana were shown to hamper lipid
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peroxidation, as measured by TBARS assay, in the same magnitude of trolox [26]. In
addition, a decoction of Salvia apiana was also emphasized for its capacity to prevent lipid
peroxidation events [25]. Moreover, decoctions of S. elegans, S. officinalis and Salvia greggii
were demonstrated to have a high capacity to scavenge NO• [27].
Rosmarinic acid and other caffeic acid derivatives were frequently reported as being
the most abundant phenolic compounds in S. africana, S. apiana and S. elegans decoctions,
while glycosidic flavones were particularly abundant in S. officinalis and S. officinalis ‘Icte-
rina’ decoctions [25–27]. In our study [25], we also concluded that the high antioxidant
potential of S. apiana decoction might be partially associated with its high levels of phe-
nolic compounds, particularly of rosmanol, a derivative of sageone, and hydroxycarnosic
acid [25]. Moreover, a significant correlation between ORAC and rosmarinic acid (R = 0.68,
p = 0.00355), was previously reported for 16 samples of commercial sage tea infusions that
were claimed to have a high content of phenolic compounds [45].
The antioxidant capacity of phenolic compounds isolated from sage plants have in fact
been underlined (Table 1). Rosmarinic acid was previously isolated from the methanolic
extracts of four Salvia species leaves (S. officinalis, Salvia glutinosa, Salvia aethiopis and S.
sclarea) and identified as a dominant radical scavenger towards the DPPH• in the HPLC–
DPPH system [61]. More recently, Pavic et al. [62] evidenced the high DPPH• scavenging
capacity of carnosol and carnosic acid, both extracted from S. officinalis by supercritical CO2
extraction. In addition, a study performed by Etsassala et al. [63] focused on the antioxidant
potential of new and known abietane diterpene compounds isolated from methanolic ex-
tracts of Salvia africana-lutea collected in South Africa. In particular, the authors described a
strong activity of 19-acetoxy-12-methoxycarnosic acid and clinopodiolides A on ORAC (1.5-
and 1.7-fold that of the reference antioxidant epigallocatechingallate, respectively), and a
high antioxidant potential of 3b-acetoxy-7a-methoxyrosmanol and clinopodiolides A on
FRAP (about 3.3-fold that of the control). The same group of researchers [64] demonstrated
that rosmanol, carnosol and 7-methoxyrosmanol exerted excellent scavenging abilities for
peroxyl radicals, as estimated by ORAC assay (six times higher than those of the refer-
ence commercial compound), while carnosol and rosmanol also exerted high antioxidant
capacity in FRAP, and in 4,7-dimethylapigenin and rosmanol with TEAC.
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Table 1. Antioxidant properties of phenolic rich extracts of distinct Salvia species (in vitro experiments).
Salvia Species Origin Solvent Extraction/Phenolics (mg/g Extract) Results of Screen Assay Ref.
S. aegyptiaca Tunisia MeOH/RA (46.3–41.7), methyl-Carn (9.6–41.4),Api-7-Glc (5.9–8.7), Lut-7-Glc (5.6–7.2)
DPPH (EC50, µg/mL): 21.1–22.6; FRAP (mM Fe(II)/mg): 149–164; ABTS
(µM TE/mg dry plant): 312–318 [41]
S. africana Portugal H2O/RA (77), Lut-O-Glr (18.7), YA-iso (30.8)
DPPH (EC50, µg/mL): 6.6 (H2O), 6.7 (AA); RP (EC50, µg/mL): 21.2
(H2O), 16.1 (BHA); β-carot bleach (EC50 µg/mL): 128.6 (H2O), 41.7
(Trolox); TBARS (EC50 µg/mL): 21.0 (H2O), 23.0 (Trolox)
[26]
S. africana-lutea South Africa
MeOH/19-acy-12-mxyCA, 3β-acy-7-mxyRos,
19-acy-7-mxyRos, 19-acy-12-mxy Car, clipd A,
clipd B (ND)
ORAC (µmol TE/g): 2588 (19-acy-12-mxyCA), 2234 (3β-acy-7-mxyRos),
735 (19-acy-7-mxyRos), 560 (19-acy-12-mxyCar), 2357 (clipd A), 1502
(clipd B), 3977 (EGCG); TEAC (µmole TE/g): 694 (19-acy-12-mxyCA), 636
(3β-acy-7-mxyRos), 124 (19-acy-7-mxyRos), 440 (19-acy-12-mxyCar), 862
(clipd A), 724 (clipd B), 4146 (EGCG); FRAP (µM acy/g): 1217
(19-acy-12-mxyCA), 2201 (3β-acy-7-mxyRos), 1440 (19-acy-7-mxyRos),
1257 (19-acy-12-mxyCar), 2263 (clipd A), 1480 (clipd B), 7525 (EGCG)
[63]
S. apiana Portugal H2O/Ros (192.4), Sage-deriv (174.1), RA (69.7),HycarAc (56.8)
DPPH (EC50, µg/mL): 13.3 (H2O), 6.7 (AA); RP (EC50, µg/mL): 55.0
(H2O), 16.1 (BHA); β-carot bleach (EC50 µg/mL): 41.2 (H2O), 41.7
(Trolox); TBARS (EC50 µg/mL): 2.79 (H2O), 23.0 (Trolox)
[25]
S. amplexicaulis Lithuania EtOH/H2O/CO2EtOH/TPC, 97.4; H2O/TPC, 5.9, mg GAE/g
ORAC (µM TE/g DW): 4735 (EtOH), 676 (H2O), 1914 (CO2); ABTS (µM
TE/g DW): 1177 (EtOH), 79.5 (H2O)
[59]
S. amplexicaulis Macedonia
DCM/Hyper (54), Coumarin (29), EA/Hyper (55),
Coumarin (30), H2O/RA (67), Kam-3-O-acetil
Glc-7-O-rhm (410), EtOH/Lut- 5-O-Glc (138),
Kam-3-O-acetil Glc-7-O-Rhm (636), MeOH/Lut-
5-O-Glc (238), Kam-3-O-acetil Glc-7-O-Rhm (298)
DPPH (EC50, µg/mL): 27.8 (EtOH), 15.8 (H2O), 15.1 (MeOH), 196.5 (EA),
593.2 (DCM), 5.1 (AA); ABTS (mg AAE/g): 2.8 (EtOH), 2.8 (H2O), 2.4
(MeOH), 0.7 (EA), 0.4 (DCM), 2.8 (BHT); FRAP (µmol Fe(II)/g): 979
(EtOH), 1372 (H2O), 1178 (MeOH), 112 (EA), 117 (DCM), 445 (BHT);
β-carot bleach (%): 40.4 (EtOH), 41.8 (H2O), 13.3 (MeOH), 58 (BHT)
[49]
S. argentea Tunisia MeOH/RA (30.9–47.2), methyl-Carn (13.1–19.4),Narn (5.4–8.7)
DPPH (EC50, µg/mL): 33.9-77.1; FRAP (mM Fe(II)/mg): 81.6-105; ABTS
(µM TE/mg ): 141–173 [41]
S. aurita South Africa MeOH/Car, Ros, 7-mxy-Ros, 12-mxy-CA,4,7-dimethyl-Api-ether (ND)
ORAC (µmole TE/g): 23962 (Car), 25790 (Ros), 23939 (7-mxy-Ros), 20247
(12-mxy-CA), 6475 (4,7-dimethyl-Api-ether), 4453 (crude extract), 3977
(EGCG); TEAC (µmole TE/g): 331 (Car), 2055 (Ros), 222 (7-mxy-Ros), 337
(12-mxy-CA), 3191 (4,7-dimethyl-Api-ether), 724 (crude extract), 4146
(EGCG); FRAP (µM AAE/g): 3918 (Car), 1522 (Ros), 1322 (7-mxy-Ros),
508 (12-mxy-CA), 610 (4,7-dimethyl-Api-ether), 394 (crude extract), 7525
(EGCG)
[64]
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Table 1. Cont.
Salvia Species Origin Solvent Extraction/Phenolics (mg/g Extract) Results of Screen Assay Ref.
S. bicolor Egypt MeOH/PrcA (75.2), CouA (70.2), GA (68.2),Lut-7-O-Glc (1.2) DPPH (EC50, µg/mL): 321 (MeOH), 250 (GA) [65]
S. cadmica Turkey
EA/RA (5.3), Lut (0.8), Api (0.5), MeOH/RA (31.1),
Lut (1.2), Hesp (0.9), H2O/RA (20.6), Lut (1.1),
Api (0.6)
DPPH (µmol TE/g dry plant): 5.9 (EA), 54.7 (MeOH), 40.5 (H2O);
CUPRAC (µmol TE/g dry plant): 20.9 (EA), 50.9 (MeOH), 54.5 (H2O);
ABTS (µmol TE/g dry plant): 7.1 (EA), 84.9 (MeOH), 102.2 (H2O); FRAP
(µmol TE/g dry plant): 13.5 (EA), 80.0 (MeOH), 98.0 (H2O)
[53]
S. elegans Portugal H2O/RA (35.5), CaffRA (17.9), SA B (7.8)
DPPH (EC50, µg/mL): 10.7 (H2O), 6.69 (AA); FRAP (EC50, µg/mL): 31.3
(H2O), 16.30 (BHA); O2•− (EC50, µg/mL): 30.6 (H2O), 7.8 (GA); NO•
(EC50, µg/mL): 91.5 (H2O), 212.1 (AA); RO2• (EC50, µM TE/mg ext):
373.1; XO (EC50 µg/mL): 71.8 (H2O), 0.09 (All)
[27]
S. fruticosa Greece: (populations1 and 2) MeOH/RA (41.9), ChlgA (1.8), CaffA (0.70)
FRAP (µM Trolox/g DW): 31.83–202.93; 135.81–326.22; ABTS (µM
Trolox/g DW): 60.94–242.3; 199.64–312.49; DPPH (µM Trolox/g DW):
182.99–192.62; 185.30–192.19, populations 1 and 2, respetively
[52]
S. greggii Portugal H2O/Lut-7-O-Glc (26.1), Api-C-hex (15.7),RA (10.9)
DPPH (EC50, µg/mL): 21.1 (H2O), 6.69 (AA); FRAP (EC50, µg/mL): 77.9
(H2O), 16.30 (BHA); O2•– (EC50, µg/mL): 61.7 (H2O), 7.8 (GA); NO•
(EC50, µg/mL): 167.8 (H2O), 212.1 (AA); RO2• (EC50, µM TE/mg ext):
335.6; XO (EC50 µg/mL): 70.1 (H2O), 0.09 (All)
[27]
S. halophila Turkey
Hexane (ND), EA/RA (48.9), CaffA (1.6),
MeOH/RA (38.6), MeOH 50%/RA (27.1),
p-OH-BA (7.5), o-coumaric (6.4), CaffA (2.4),
Lut-Glc (2.3), H2O/RA (5.9)
DPPH (EC50, mg/mL): 0.4 (EA), 0.6 (50% MeOH), 1.0 (H2O, MeOH);
FRAP (AAE mmol/g extract): 1.0 (EA, 50% MeOH), <1.0 (H2O, MeOH,
Hexane), 0.025 (GA); β-carot bleach (AA%): 80 (Hexan), 65 (EA), <40
(MeOH, 50% MeOH, H2O), 90 (BHT); Iron (II) Thiocyanate (%): 91
(hexan), 89 (EA), 70 (50% MeOH), 68 (H2O), 18 (MeOH), 90 (BHT at 1%);
TBARS (%): 94 (hexan), 91 (H2O), 82 (50% MeOH), 80 (EA), 52 (MeOH),
90 (BHT at 1%)
[54]
S. miltiorrhiza Commercial H2O/TPC 66.27; 95% EtOH/TPC 4.97 mg GAE/g DPPH (EC50, µM AE/g): 202 (H2O), 105 (EtOH) [66]
S. miltiorrhiza China H2O/Danshensu, SA A, SA B DPPH (EC50, µg/mL): 131; ORAC (µmol/g): 757 [67]
S. nemorosa Lithuania EtOH/H2O/CO2EtOH/TPC (108.7), H2O/TPC 7.6 mg GAE/g
ORAC (µM TE/g DW): 2392 (EtOH), 718 (H2O), 1193 (CO2); ABTS (µM
TE/g DW): 1005 (EtOH), 150 (H2O)
[59]
S. nemorosa Iran 80% MeOH/TPC 30.4 mg GAE/g dried plant DPPH (EC50, µg/mL): 138.4 (80% MeOH), 1.79 (Que) [16]
S. nemorosa Iran MeOH/RA (7.5), CaffA (0.11), Que (0.15) DPPH (EC50, µg/mL): 82 (MeOH), 64 (BHT) [58]
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Table 1. Cont.
Salvia Species Origin Solvent Extraction/Phenolics (mg/g Extract) Results of Screen Assay Ref.
S. nemorosa Iran MeOH/TPC, 114 mg TAE/g DPPH (EC50 µg/mL): 473 (MeOH), 211 (BHT); β-carot bleach (%): 20(MeOH), < 20% (BHT, at 500 µg/mL) [40]
S. officinalis Portugal H2O/Api-O-Glr (48.4), RA (287.3), Scu-O-Glr (13.4)
DPPH (EC50, µg/mL): 34.8 (H2O), 6.69 (AA); FRAP (EC50, µg/mL): 40.0
(H2O), 16.30 (BHA); O2•– (EC50, µg/mL): 32.8 (H2O), 7.8 (GA); NO•
(EC50, µg/mL): 118.2 (H2O), 212.1 (AA); RO2• (EC50, µM TE/mg ext):
404.4; XO (EC50 µg/mL): 55.1 (H2O), 0.09 (All)
[27]
S. officinalis Iran MeOH/TPC, 86.4 mg TAE/g DPPH (EC50 µg/mL): 233 (MeOH), 211 (BHT); β-carot bleach (%): 79(MeOH), < 20% (BHT, at 500 µg/mL) [40]
S. officinalis Algerian MeOH-H2O/TPC, 30 mg GAE/g
DPPH (EC50 µg/mL): 1.98; ABTS (EC50 µg/mL): 4.79; OH•(IC50 µg/mL):
1.36 [43]
S. officinalis Portugal DE/TPC 9.3, EA/TPC 7.0, n-but/TPC 23.9,H2O/TPC 3.3, mg GAE/ml
DPPH (EC50 µg/mL): 3.9 (EA), 4.1 (n-but), 2.8 (H2O); O2•- scav (EC50
µg/mL): 5.5 (DE), 5.3 (EA), 8.9 (n-but) 10.1 (H2O)
[42]
S. officinalis Spain
H2O inf/RA (73.9), Lut-O-Glc (37.4), Lut-O-Glr
(88.1), H2O dec/RA (93.5), Lut-O-Glc (52.2),
Lut-O-Glr (129.8), 80% MeOH/RA (93.2),
Lut-O-Glc (56.1), Lut-O-Glr (94.7)
DPPH (EC50 µg/mL): 96 (H2O inf), 75.5 (H2O dec), 33 (80% MeOH); RP
(IC50 µg/mL): 84 (H2O inf), 66.5 (H2O dec), 25 (80% MeOH); β-carot
bleach (EC50 µg/mL): 139 (H2O inf), 50.9 (H2O dec), 6.6 (80% MeOH);
TBARS (EC50 µg/mL): 18.0 (H2O inf), 10.4 (H2O dec), 2.1 (80% MeOH)
[46]
S. officinalis Lithuania EtOH/H2O/CO2EtOH/TPC, 120.7; H2O/TPC, 13.2, mg GAE/g
ORAC (µM TE/g DW): 2535 (EtOH), 1143 (H2O), 6015 (CO2); ABTS (µM
TE/g DW): 1080 (EtOH), 225 (H2O)
[59]
S. officinalis Commercial H2O, MeOH/RA (16.3), SA K isomer (2.7), Lut-hex(2.7), Api-Glr (4.3)
DPPH (EC50, µg/mL): 69 (MeOH), 2.79 (Que); ABTS (EC50 µg/mL): 19.9
(MeOH), 50.8 (H2O), 1.17 (Que)
[44]
S. officinalis Commercial Infusion/RA (12.2–296), Lut-7-O-Glr (37.9–166),CA (9.1–32.9) mg/L. ORAC (mmol TE/100mL): 0.4 to 1.8 [45]
S. officinalis Tunisia MeOH/RA (65.1–79.9), methyl-Carn (22.9–34.6),CA (15.8–24.0), Car (23.8–25.8)
DPPH (EC50, µg/mL): 3.4–10.1; FRAP (mM Fe/mg): 179–197; ABTS (µM
TE/mg): 645–766 [41]
S. officinalis Portugal
Soxhlet extraction: EtOH, EtOH-H2O/RA (0.443),
Car (0.935), CA (0.948); TPC 685.2, 606.3, 227.2 mg
GA/g extract, respectively;
Traditional extraction: H2O, EtOH-H2O/RA
(0.443); TPC 528.2 and 464.5 mg GA/g extract,
respectively)
Soxhlet extraction: DPPH (EC50, µg/mL): 116.5 (H2O), 124.7 (EtOH-H2O),
252.3 (EtOH); ABTS (EC50 µg/mL): 88.2 (H2O), 99.3 (EtOH-H2O), 170.6
(EtOH); RO2• (EC50 µg/mL): 0.61 (H2O), 0.52 (EtOH-H2O), 1.35 (EtOH)
Traditional extraction: DPPH (EC50, µg/mL): 157.0 (H2O), 131.3
(EtOH-H2O); ABTS (EC50 µg/mL): 125.2 (H2O), 114.5 (EtOH-H2O);
RO2•(EC50 µg/mL): 0.69 (H2O), 0.52 (EtOH-H2O)
[47]
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Table 1. Cont.
Salvia Species Origin Solvent Extraction/Phenolics (mg/g Extract) Results of Screen Assay Ref.
S.
officinalis‘Icterina’ Portugal
H2O/RA (52.7), Api-O-Glr (32.8),
Lut-7-O-Glr (18.2)
DPPH (EC50, µg/mL): 10.4 (H2O), 6.68 (AA); RP (EC50, µg/mL): 42.3
(H2O), 16.1 (BHA); β-carot bleach (EC50 µg/mL): 146.6 (H2O), 41.7
(Trolox); TBARS (EC50 µg/mL): 23.0 (H2O), 23.0 (Trolox)
[26]
S. palaestina Jordan n-but/Sal, methyl-3-O-methyl-Rsm,Lut-7-O-(2´´-p-hyb)-β-Glr (ND) DPPH (EC50, µg/mL): 3.01 (Sal); 1.0 (methyl-3-O-methyl-Rsm), 1.1 (BHA) [68]
S. ringens Macedonia
EtOH/Kam-3-O-acetil-Glc-7-O-Rhm (465), rutin
(77), MeOH/RA (36), Kam-3-O- acetil-Glc
-7-O-Rhm (287), Rutin (173), DCM/Hyperoside
(128), EA (Lut (27),
Kam-3-O-acetil-Glc-7-O-Rhm (120)
DPPH (EC50, µg/mL): 17.3 (EtOH), 20.3 (MeOH), 266.2 (DCM), 22.2 (EA),
5.1 (AA); ABTS (mg AAE/g): 2.44 (EtOH), 1.19 (MeOH), 0.58 (DCM), 2.36
(EA), 2.8 (BHT); FRAP (µmol Fe(II)/g): 1088.3 (EtOH), 274.8 (MeOH),
191.1 (DCM), 969.8 (EA), 180 (AA)
[50]
S. sclarea Lithuania EtOH/H2O/CO2EtOH/TPC, 106.2, H2O/TPC 7.6 mg GAE/g
ORAC (µM TE/g DW): 3820 (EtOH), 867 (H2O), 570 (CO2); ABTS (µM
TE/g DW): 1634 (EtOH), 153 (H2O)
[59]
S. sclarea Iran 80% MeOH/TPC 14.8 mg GAE/g dried plant) DPPH (EC50, µg/mL): 190.7 (80% MeOH), 1.79 (Que) [16]
S. sclarea Iran MeOH/TPC, 103.3 mg TAE/g DPPH (EC50 µg/mL): 290 (MeOH), 211 (BHT); β-carot bleach (%): 35(MeOH), < 20% (BHT, at 500 µg/mL) [40]
S. sclarea Serbia EtOH/RA (165.3), Lut-7-Glc (5.6), Api-7-Glc (8.5) DPPH (EC50 µg/mL): 27.8 (EtOH), 6.1 (RA), 2.4 (BHA); β-carot bleach(EC50 µg/mL): 19.1 (EtOH), 32.6 (RA), 0.04 (BHA)
[57]
S. syriaca Iran n-hex, DMC, MeOH/Rut (9.43), Que (0.15), Api(0.24), FA (0.19), RA (0.63) DPPH (EC50 µg/mL): 210 (n-hex), 245 (DMC), 70 (MeOH), 66 (BHT) [51]
S. verbenaca Tunisia MeOH/RA (36.9–53.5), Narn (2.9–7.5), Nar(2.4–3.7)
DPPH (EC50 µg/mL): 23–36.3; FRAP (mM Fe(II)/mg): 106–159; ABTS
(µM TE/mg ): 165–205 [41]
S. virgata Iran MeOH/TPC 33.8 mg TAE/g DPPH (EC50 µg/mL): 198 (MeOH), 211 (BHT); ↓β-carot bleach (%): 95(MeOH), <20% (BHT, at 500 µg/mL) [40]
Other Salvia species
S. cereal (S. c), S.
reuterana (S. r), S.
persica (S. p)
Iran MeOH /TPC 45.7–82.9 mg TAE/g DPPH (EC50 µg/mL): 598 (S. r), 883 (S. cl), 1810 (S. p), 211 (BHT); β-carotbleach (%): 30 (S. r), 55 (S. c), 95 (S. p), <20% (BHT, at 500 µg/mL) [40]
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South Africa MeOH:CHCl3 /TPC 45.6–212 mg GAE/g
DPPH (EC50, µg/mL): 1.61 ( S. schlechteri), 74.2 (S. garipensis), >100 (S.
dolomitica, S. radula), 11.1–68.1 (Others); ABTS (EC50, µg/mL): 11.9 (S.
muirii), 69.3 (S. radula), 14.6–50 (Others)
[48]
AA—ascorbic acid; AAE—ascorbic acid equivalent; AE—Ascorbate equivalent; ABTS—2.2′-azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) radical scavenging assay; acy—acetoxy; Api—apigenin;
BA—benzoic acid; BHA—2(3)-t-butyl-4-hydroxyanisole; BHT—3.5-di-tert-butyl-4 hydroxytoluene; CA—carnosis acid; CaffA/CaffA deriv—caffeic acid/caffeic acid derivative; Car—carnosol; Carn—carnosate;
ChlgA—chlorogenic acid; Clipd—clinopodiolides; β-carot bleach—β-carotene/linoleic acid bleaching inhibition assay; CouA—coumaric acid; CUPRAC—cupric ion reducing antioxidant capacity; Deriv—
derivatives; DCM—dichloromethane; DE—diethyl ether; dec—decoction; DPPH—2.2-diphenyl-1-picrylhydrazyl radical scavenging assay; DW—dry weight; EA—ethyl acetate; EGCG—epigallocatechin
gallate, EtOH—ethanol; FA—ferulic acid; Flav—flavonoids; FRAP—ferric reducing antioxidant power; GA—gallic acid; GAE—gallic acid equivalents; Glc—glucoside; Glr—glucuronide; Hesp—hesperidin;
Hex—hexoside; Hyb—hydroxybenzoyl; HycarAc—Hydroxycarnosic acid; Hyper—hyperoside; I—inhibition; inf—infusion; iso—isomer; Kam—kaempferol; Lut—luteolin; MeOH—methanol; mxy—methoxy;
Nar—naringin; Narn—naringenin; n-but—n-butanol; ND—not determined; NO—nitric oxide radical scavenging assay; OH•—hydroxyl radical scavenging assay; O2•—radical scavenging assay; ORAC—oxygen
radical absorbance capacity; p-OH-BA—p-hydroxybenzoic acid; PrcA—protocatchuic acid; QA—quinic acid; Que—quercetin; RA—rosmarinic acid; Rhm—rhamnoside; RP—reducing power; RO2•—Peroxy
radical inhibition assay; Ros—rosmanol; Rsm—rosmarinat; SA—salvianolic acid; Sal—salpalaestinin; Sage — sageone; Scu—scutelarein; SH—reduced thiol groups; TAC—total antioxidant capacity; TAE—tannic
acid equivalent; TBARS—thiobarbituric acid reactive substances assay; TE—trolox equivalent; TEAC—trolox equivalent absorbance capacity; TPC—total phenolic content; XO—xanthine oxidase inhibition assay;
YA—Yunnaneic acid.
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1.1.2. Antioxidant Activity of Salvia Extracts—In Vitro Cellular and In Vivo Methods
Although less investigated, the antioxidant abilities of polar extracts from Salvias
have also been demonstrated in cellular and/or in vivo models (Table 2). As previously
mentioned, DNA can be dramatically damaged under oxidative stress conditions. Notably,
the treatment of H2O2-induced human colon carcinoma Caco-2 and human cervical cancer
HeLa cells with aqueous extracts of S. officinalis and S. fruticosa for 24 h resulted in a
protective effect on DNA damage [69], as measured through the comet assay. This effect was
also observed for the two major phenolic constituents of the extracts (rosmarinic acid and
luteolin-7-O-glucoside), thereby emphasizing their possible intervention in this mechanism.
The same authors also reported promising results in assays of DNA repair, as evaluated in
oxidative-induced Caco-2 cells. In these experimental conditions, independent treatment
with both extracts (50 µg/mL), as well as with luteolin-7-O-glucoside (20 µM), were able to
increase the rate of rejoining of DNA strand breaks [69]. Notably, Kosics et al. [44] reported
that the protective effects of S. officinalis aqueous extracts (rich in rosmarinic acid) against
DNA damage induced by strong oxidants (H2O2 and DMNQ), achieved the highest DNA-
protective capacity at 2 mg/mL [44]. On another hand, in a study performed by Tavakkoli
et al. [70], the methanolic extracts of Salvia santolinifolia Boiss. and S. sclarea L. (100 µg/mL)
were demonstrated to reduce the H2O2-stimulated increase in ROS production, in neuronal
PC12 cells, by 61.9% and 61.4%, respectively. In the same study, the S. santolinifolia extract
was also shown to significantly reduce H2O2-induced apoptosis [70]. Likewise, methanolic
extracts of S. hydrangea and S. sclarea (≤ 50 µg/ml) were shown to fight DNA oxidative
damage of PC12 neural cells induced by Fe(II)–H2O2 [56]. Additionally, neuroprotective
effects of Salvia extracts from S. hydrangea, S. lachnocalyx, S. macilenta, S. multicalis, S. sclarea
and S. xanthocheila against oxidative stress (using H2O2 as oxidative agent), were observed
in PC12 neural cells, for which pretreatment with 100 µg/mL significantly protected cell
survival (76% to 93%) with respect to the control [56]. Moreover, the antioxidant activity of
phenolic acids isolated from S. officinalis was demonstrated to offer protection of PC12 cells
from injury (54.2% for salvianolic acid Y and 35.2% for salvianolic acid B) [71].
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Table 2. Antioxidant properties of phenolic rich extracts of distinct Salvia species (in vitro cellular assays and in vivo experiments).
Salvia Species Origin Solvent Extraction/Phenolics (mg/g Extract) Results of Screen Assay Ref.
In Vitro cellular assays
S. hydrangea (S.h), S. sclarea (S. s) Iran MeOH/TPC: S.h 238, S.s 268, mg GA/g
Inhibition of DNA oxidative damage of neuronal PC12 cells after
tratment with 10 µg/mL extract; protection cell survival at 93% (S.
h) and 78% (S. s; both 100 µg/mL), in comparision to control.
[56]
S. officinalis (S. o), S. fruticosa (S. f ), S.
lavandulaefolia (S. l) Portugal H2O (ND)
DNA protection against strand breaks induced by H2O2, 2h: 21%
(HeLa cells, S. l), 26% (Caco-2 cells, S. f ), at 50 µg/mL extract; 62%
(Caco-2 cells, L-O-G), at 20 µM; DNA repair in Caco-2 cells: 62% (S.
o), 86% (S. f ), at 50 µg/mL extract; 74% (L-O-G), at 20 µM
[69]
S. officinalis Commercial H2O, MeOH/RA (16.3), SA K isomer (2.7),Lut-hex (2.7), Api-Glr (4.3)
HepG2 DNA damage induced by H2O2 and DMNQ: ↓ after 2
mg/mL extracts, at 24h / enzymatic activity: ↑GPx, ↓SOD, after 4, 2
and 1 mg/mL extracts
[44]
S. santolinifolia Boiss. (S. san), S.
sclarea L. (S. s) Iran MeOH-H2O (ND)
Protective effects of H2O2-induced intracellular ROS in neuronal
PC12 cells (% I): 61.9 (S. s), 61.4 (S. san); inhibition of apoptosis:
extract S. s at 100 µg/mL
[70]
In Vivo experiments
S. euphratica Montbret, Aucher &
Rech. f. var. euphratica (S. e), S.
kronenburgii Rech. f. (S. k)
Turkey EtOH 0.5% or 1% (w/w)/TPC: S. k 41.8, S. e76.2 mg GAE/g
Ointment application in wound model skin samples from rats, after
7/14 days
S. k: NO (16.5/21.8), MDA (8.4/7.5), GSH (11.26/10.01), at 0.5%;
S. k: NO (20.9/10.9), MDA (7.9/5.67), GSH (7.6/7.2), at 1%;
S. e: NO (28.7/11.6), MDA (8.5/7.2), GSH (15.5/7.3), at 0.5%;
S. e: NO (20.8/10.3), MDA (8.1/4.6), GSH (9.3/6.2), at 1%;
Positive control: NO (20.1/18.5), MDA (12.3/7.42), GSH
(11.27/7.93)
[72]
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Table 2. Cont.
Salvia Species Origin Solvent Extraction/Phenolics (mg/g Extract) Results of Screen Assay Ref.
S. officinalis Tunisia H2O/p-CouA (0.28), SA (0.27)
Protective effects of EtOH-induced gastric and small bowel injuries
by alcohol in Wistar rats after treatment with H2O-extract (at 100
and 200 mg/Kg bw), sulf (at 100 mg/Kg bw) and mix (H2O-extract
at 50 mg/Kg bw + sulf at 50 mg/Kg bw): ↓MDA (nmol/mg protein)
and ↓H2O2 (mmol/mg protein) content, p < 0.05 compared to
EtOH group;
↑SOD (U/mg protein), ↑CAT (µM H2O2/min/mg protein) and
↑GPx (nmol GSH/min/mg protein) activity, ↑GSH (nmol/mg
protein) and ↑SH (µmol/mg protein), p < 0.05 compared to
EtOH group.
[60]
S. officinalis Commercial Liquid extract (ND)
(LPS)-induced inflammation restoration in rats after orally
treatment: ↓MDA level (nm/mL/mg Hb) in erytrocyte hemolysate
(2.99 at 10 mg/Kg; 2.66 at 30 mg/Kg extract), p < 0.001compared to
control and inflammation groups); ↓MDA (nmol/mL) in kidney
(2.20 at 10 mg/Kg; 2.15 at 30 mg/Kg extract); ↑SOD % I in
erytrocyte hemolysate (67 at 10 mg/Kg; 72 at 30 mg/Kg extract), in
liver (84 at 10 mg/Kg; 86 at 30 mg/Kg extract) and in lung (89 at 10
mg/Kg; 94 at 30 mg/Kg extract); ↑CAT (nmol/min/mL) in
erytrocyte hemolysate, kidney and lung (1.68 to 13 at 10 mg/Kg;
1.77 to 9.7 at 30 mg/Kg extract); ↑GPx (nmol/min/mL) in liver,
kidney and lung (88 to 147 at 10 mg/Kg; 99 to 160 at 30 mg/Kg
extract); ↓NO (µmol/L) in liver (1.08 at 30 mg/Kg extract), kidney
(3.19 at 10 mg/Kg and 0.77 at 30 mg/Kg extract) and blood plasma
(0.87 at 10 mg/Kg); p < 0.001 or p < 0.05 compared to
inflammation group)
[73]
S. officinalis Slovakia EtOH (ND)
Oxidative stress restoration of rats hepatocytes: ↑DNA protection
against lesions induced by H2O2, p < 0.001; ↑GSH, p < 0.01; ↑GPx
(0.0057–0.0062 U/mg protein) after treatment with 6.67–13.3 mg/ml
extract in drinking water, p < 0.001
[74]
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Table 2. Cont.
Salvia Species Origin Solvent Extraction/Phenolics (mg/g Extract) Results of Screen Assay Ref.
S. przewalskii Commercial H2O/SA B (55), RA (316)
Oxidative stress restoration of rats-injured podocytes induced by
PAN: ↓8-OHdG after tratment with extract on days 5, 10 and 15;
↓ROS after tratment with extract (158 µg/ml), SA B (8.5 µg/ml), RA
(50 µg/ml), control (1 µg/ml), at 24 and 48 h; ↓apoptosis after
tratment with extract (316 µg/ml), SA B (17 µg/ml)
[75]
S. sahendica Iran MeOH/TPC, 64.5, EtOH/TPC: 31.1 mgGAE/g
Oxidative stress restoration of rats liver and kidney damage
induced by alcohol: ↑SOD, CAT, GPx and GST (four enzymes,
U/mg protein),↑GSH (mg/100 g tissue), vit C and E (µmol/mg
tissue), after tratment with 0.1 g/kg bw compared to untreated
alcoholic rats, p < 0.05
[76]
S. triloba Egypt MeOH (ND)
Oxidative stress status restoration of Alzheimer’s disease (AD)
induced in rats: ↓serum MDA (%I: 19.65% and 12.9%), ↓serum NO
(%I: 36.2 and 21.9); serum TAC (↑33.4% and 26.7%), serum SOD
(↑17.3% and 4.2%) after treatment with 750 and 375 mg/kg bw,
respectively, p < 0.05 comparing to AD group
[77]
AD—Alzheimer’s disease; All—allopurinol; Api—apigenin; bw—body weight; Caco-2 cells—human colon carcinoma cells; CAT—catalase; CouA—coumaric acid; DMNQ—2,3-dimethoxy-1,4-naphthoquinone;
EtOH—ethanol; GA—gallic acid; GAE—gallic acid equivalents; Glc—glucoside; Glr—glucuronide; GPx—glutathione peroxidase; GSH—reduced glutathione; GST—glutathione-S-transferase, Hb—hemoglobin;
HeLa—cervical carcinoma cells; HepG2—hepatocellular carcinoma cells; Hex—hexoside; LPS—lipopolysaccharide; Lut—luteolin; MDA—malondialdehyde; MeOH—methanol; ND—not determined; NO—nitric
oxide; PAN—puromycin aminonucleoside; PC12—neuronal cells; RA—rosmarinic acid; ROS—reactive oxygen species; SA—salvianolic acid; SOD—superoxide dismutase; Sulf—sulfasalazine, TAC—total
antioxidant capacity; TPC—total phenolic content; vit—vitamin.
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In vivo studies demonstrating antioxidant-related effects of Salvia extracts were per-
formed either by oral administration and/or intravenous injection. In particular, the oral
administration for one month of a methanolic extract of Salvia sahendica (0.1 g/kg), caused
a significant decrease of malondialdehyde (MDA) and hydroperoxide levels, in liver and
kidney of rats with alcohol-induced damage [76]. In addition, this intake restored the
levels of non-enzymatic antioxidants (GSH, vitamin C, vitamin E) while increasing the
activities of antioxidant enzymes (SOD, CAT, GPx and GST) [76]. In research performed
by Horváthová et al. [74] in hepatocytes isolated from rats upon supplementation with
S. officinalis ethanolic extract (13.33 mg/ml) for 14 days, a decrease of oxidative DNA
damage was registered, based on the comet assay. Regardless of this, the SOD level was
not changed; the authors demonstrated that the sage extract significantly increased the
levels of GSH and GPx, suggesting that the consumption of S. officinalis may potentiate
resistance to oxidative stress and afford hepatoprotection [74].
More recently, an S. officinalis decoction was shown to significantly reverse the levels of
MDA and H2O2, in gastric and intestinal tissues of ethanol-induced gastric and small bowel-
injured rats, after 15 days of oral administration [60]. In this study, treatment with sage
decoction also significantly counteracted (in a dose-related manner) the decreased activities
of enzymatic antioxidants SOD and GPx, and levels of the nonenzymatic antioxidant GSH,
which were induced by alcohol administration. Overall, the results indicated that the
administration of S. officinalis decoction and sulfasalazine (i.e., a drug used in the treatment
of inflammatory bowel disease), alone or in combination, abolished acute ethanolic-induced
oxidative stress in the gastric and duodenal mucosa, a fact that the authors attributed to
the high amount of phenolic acids and flavonoids in the sage extract [60].
Several authors also demonstrated the benefits of Salvia commercial polar extracts
towards oxidative-stress related disorders. In a study performed by Kolac et al. [73], a
commercial extract of S. officinalis was administered orally to a lipopolysaccharide (LPS)-
induced experimental inflammation animal model for two days, with the aim of investi-
gating the potential antioxidants of the sage as a therapeutic approach in inflammatory
diseases [73]. Among the samples evaluated, the authors underlined that the extract of S.
officinalis (10 and 30 mg/kg) could increase the levels of CAT, SOD, and GPx in the lung,
kidney, liver, and erythrocyte hemolysates in treatment groups, and reverse LPS-induced
decreases in endogenous antioxidants. Additionally, the sage extract used in the treatment
groups (inflammation + S. officinalis 10 and 30 mg/kg) decreased the levels of MDA in all
samples, and reduced NO levels in the kidney as well, preventing the harmful effects of
oxidative stress [73].
Several sage plants have also been tested for protective effects on renal disease. In
a study performed by Liu et al. [75], a commercial extract of Salvia przewalskii (SPE) was
shown to attenuate oxidative stress in puromycin aminonucleoside (PAN)-induced rat
podocyte injury, via antioxidative stress effects—which is reflected by a significant reduc-
tion in 8-oxo-2’-deoxyguanosine, a marker of oxidative DNA damage. In the same study,
antioxidative stress effects were observed against experimental PAN-induced nephrosis
by suppression of ROS levels and podocyte integrity cytoskeleton-restoration, after treat-
ment with SPE. Notably, isolated salvianolic acid B was demonstrated to be as potent as
tacrolimus (i.e., a compound that has been used to protect podocytes of glomerular dis-
eases) [75]. The authors also observed significant positive correlations between podocyte
apoptosis rates and the ROS levels of groups treated with SPE, as well as the isolated
compound salvianolic acid B and rosmarinic acid (r range of 0.998 to 1.0), suggesting that
a decrease in intracellular ROS levels may inhibit PAN-induced apoptosis of cultured
podocytes [75].
Due to the traditional use of several Salvia species as memory-enhancing agents,
researchers have also focused their attention on the evaluation of these plants as candidates
for new Alzheimer’s disease (AD) drugs, able to ameliorate the oxidative effects associated
with this disease. In particular, Mahdy et al. [77] reported that the treatment of AD-induced
rats with a methanolic extract of Salvia triloba at 750 and 375 mg/kg body weight for three
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months, induced a significant decrease in serum MDA (–19.65% and –12.9%) and NO levels
(−36.21% and –21.94%), and a simultaneous increase of serum total antioxidant capacity
(TAC; 33.39 and 26.67%) and SOD levels (17.27% and 4.20%) respectively, in comparison to
an AD-induced untreated positive control group [77].
In vivo studies also support the hypothesis that Salvia phenolic-rich extracts may
counteract distinct mechanisms of inflammation and oxidative processes, namely the
wound healing capacity. Indeed, in a study performed by Guzel et al. [72], biomechanical
parameters were evaluated after topical application of ointments obtained from ethanolic
extracts of Salvia kronenburgii Rech. f. (SK) and Salvia euphratica Montbret, Aucher & Rech.
f. var. euphratica (SE; 0.5% and 1% (w/w)) in incision wound model skin samples from
diabetic rats. The authors showed that such treatment reduced NO levels in the SK (1%), SE
(0.5%), and SE (1%)-treated groups—which were significantly different from the positive
control—after 14 days of ointment application [72]. Moreover, MDA levels of SK and SE
ointment-treated groups (0.5 and 1%) were reduced in comparison to the positive control-
treated group after 14-day application, while an increase in non-enzymatic antioxidant
GSH levels was observed in the SE group (0.5%) on day 7 [72]. The wound tissues had
increased levels of ROS production, while the reduction of NO and MDA levels observed
in these tissues, were postulated by the authors as related to the antioxidant capacities of
the extracts, particularly due to their richness in phenolics [72].
1.2. Antidiabetic and Anti-Obesity Properties
Currently, the number of individuals who are overweight and obese has become a
great concern to the World Health Organization (WHO) [78]. In 2016, more than 1.9 billion
adults (18 years and older) were overweight, and of these, over 650 million were obese [79].
For this reason, the overall goal of the WHO strategy is to promote and protect health
through healthy eating and physical activity [78]. Overweight and obesity pose a major
risk for other health concerns like dyslipidemia, type 2 diabetes mellitus, coronary artery
disease, and hypertension—which are in turn all considered risk factors for cardiovascular
disease [80]. The singular metabolic dyslipidemia of obesity consists of increased triglyc-
erides, associated with low levels of high-density lipoprotein (HDL) cholesterol and normal
or slightly increased low-density lipoprotein (LDL) cholesterol [80]. Diabetes mellitus is
also recognized as an increasingly serious threat to global public health, characterized by
deficient plasma glucose regulation, that has been associated with sedentary lifestyles and
unhealthy dietary habits [78]. In this instance, the risk of developing obesity and type
2 diabetes could be reduced by the changing of dietary patterns and particularly by the
regular consumption of natural products such as phenolic-rich plants [3,81–83].
Phenolic compounds, especially flavonoids and phenolic acids, have been claimed
to control the risks of metabolic syndrome, a cluster of hypertension, dyslipidemia, obe-
sity and associated disorders (e.g., cardiovascular disease, neuropathy, nephropathy and
retinopathy) [3,81]. In particular, these compounds were shown to inhibit the activity of
key digestive enzymes involved in the metabolism of carbohydrates and lipids, namely
α-glucosidase, α-amylase and pancreatic lipase. α-Amylase and α-glucosidase are respon-
sible for the digestion of dietary carbohydrates to glucose, which enters the blood stream.
The inhibition of these two enzymes results in the slowing of liberation and absorption of
glucose, consequently reducing levels of blood glucose and ultimately contributing to the
suppress of hyperglycemia and managing of diabetes [3,84,85]. In turn, lipase inhibition
decreases the digestion of dietary triglycerides in the small intestine [86]. Dietary plant
polyphenols may modulate other relevant events: e.g., fighting against body weight (bw)
gain, fat deposition and adipocyte dysfunction and weakening oxidative stress and related
inflammatory processes, among others [3,84–86].
In the following section, a summary of antidiabetic and anti-obesity properties of
Salvia extracts is presented based on in vitro and in vivo studies, including clinical trials.
Whenever possible, correlations to active phenolic compounds are also described.
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1.2.1. Antidiabetic and Anti-Obesity Properties of Salvia Extracts—In Vitro methods
Several authors reported the high capacity of distinct methanolic extracts, or of aque-
ous extracts, from Salvia species, in inhibiting α-glucosidase activity, including that of S.
officinalis, Salvia acetabulosa, S. nemorosa, S. syriaca, Salvia chloroleuca, S. elegans, S. cadmica,
S. africana-lutea, S. aurita, S. blepharochlaena, S. euphratica var. leiocalycina and S.verticillata
subsp. amasiaca [27,51,53,58,63,64,87–89], which in some cases were even more effective
than the antidiabetic pharmaceutical drug acarbose (Table 3). In these studies, the authors
have essentially correlated this ability with the phenolic constituents of the extracts; e.g., a
strong correlation (r = 0.995) was found for the contents of caffeic acid and of caffeic acid
derivatives (ranging from 20.8 to 74.1 mg/g extract), in aqueous extracts of S. officinalis, S.
elegans and S. greggii, and α-glucosidase inhibition [27]. Likewise, when describing the high
inhibitory capacity of aqueous and methanolic extracts of S. cadmica (both rich in rosmarinic
acid, luteolin and apigenin) towards α-glucosidase and α-amylase, Kocak and cowokers
underlined a strong correlation between the α-glucosidase inhibitory capacity with TPC
(r = 0.986) and TFC (r = 0.917) [53]. In addition, in the study of Bahadori et al. [58], the
authors associated the strong α-glucosidase inhibitory capacity of the methanolic extract
of S. nemorosa with its richness in phenolic and flavonoid compounds, namely rosmarinic
acid, quercetin and caffeic acid (0.11 to 7.6 mg/g extract).
The ability of sage phenolic compounds in acting as inhibitory agents of α-glucosidase
has in fact been proved by distinct researchers; e.g., isosalvianolic acid C methyl ester,
rosmarinic acid methyl ester and salvianolic acid A and C methyl ester, isolated from Salvia
miltiorrhiza, were reported to be stronger inhibitors of α-glucosidase than acarbose [90].
Likewise, the flavonoids luteolin-7-O-glucoside, luteolin-7-O-glucuronide and diosmetin-7-
O-glucuronide, obtained from the aerial parts of S. chloroleuca, were also shown to exert
α-glucosidase inhibitory effects close to that of acarbose (IC50 of 18.3, 14.7, and 17.1 µM,
respectively, vs 16.1 µM) [89].
In addition to caffeic acid derivatives and flavonoids, some authors also underlined
the efficacy of phenolic terpenoids from sage origin to inhibit α-glucosidase and/or α-
amylase [63,64]. In particular, 7-methoxyrosmanol and rosmanol purified from S. aurita,
were reported to be potent α-glucosidase inhibitory agents (IC50 of 4.2 and 16.4 µg/mL,
respectively), while 12-methoxycarnosic acid and carnosol actively inhibited α-amylase
(IC50 of 16.2 and 19.8 µg/mL, respectively) [64]. Note that phenolic diterpenic compounds
have been also claimed to act as antidiabetic agents by several other mechanisms, such as
by reversing insulin resistance, modulating mediators of the insulin signaling pathway,
promoting glycogen synthesis, inhibiting glycogen degradation, decreasing free fatty acids,
inhibition of gluconeogenesis and decreasing blood glucose levels [82,83]. Moreover, non-
phenolic compounds, namely terpenoids, have been also claimed as potential agents for the
control of metabolic enzymes. In the study of Etsassala et al. [63], ursolic acid and β-amyrin
isolated from a methanolic extract of S. africana-lutea, were shown to be strong inhibitors of
α-glucosidase (IC50 values of 11.3 and 17.1 µg/mL, respectively). Additionally, oleanolic
acid purified from the same source displayed both high α-glucosidase and α-amylase
inhibitory activity (IC50 of 22.9 and 12.5 µg/mL, respectively) [63].
Although less investigated, the ability of polar Salvia extracts to inhibit lipase was
previously reported. In particular, methanolic extracts obtained from S. officinalis leaves [91]
and from S. triloba [92], and dichloromethane extracts of other sage species, were previously
reported to hold this ability [87]. In the study of Ninomiya et al. [91], the authors also
emphasized the ability of the phenolic diterpenes carnosic acid and carnosol, isolated from
leaves of S. officinalis, to control the activity of pancreatic lipase [91]. On the other hand,
Zengin et al. [87] showed that dichloromethane extracts of S. euphratica var. Leiocalycina,
S. blepharochlaena, and S. verticillata subsp. Amasiacawere, were more active against lipase
(potencies 65–69 mg orlistat equivalent/g extract) than methanolic and water extracts from
the same plant origins.
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Table 3. Antidiabetic and anti-obesity properties of phenolic-enriched extracts of distinct Salvia species—in vitro experiments.
Salvia Species Origin Solvent Extraction/Phenolics (mg/g Extract) Results of Screen Assay Ref.
S. africana-lutea South Africa MeOH/OlA, UrA, β-amyrin (ND) α-GlucI (IC50,): 11.3 ± 1.0 (UrA), 17.1 ± 1.0 (β-amyrin) and 22.9 ± 2.0 (OlA),610.4 ± 1.0 (Acar); α-AmI (IC50, µg/mL): 12.5 ± 0.7 (OlA), 12.2 ± 0.6 (Acar)
[63]
S. aurita South Africa MeOH/4,7-dimethyl-Api-ether, 7-mxy-Ros,12-mxy-CA, Ros, Car (ND)
α-GlucI (IC50, µg/mL): 4.2 ± 0.7 (7-my-Ros), 16.4 ± 1.1 (Ros), 610.4 ± 1.0
(Acar); α-AmI (IC50, µg/mL): 16.2 ± 0.3 (12-12-my-CA), 19.8 ± 1.4 (Car),
12.2 ± 0.6 (Acar)
[64]
S. blepharochlaena Turkey H2O, DCM, MeOH/RA (22), Lut-O-hex (7.2)
α-AmI (mmol ACAE/g extract): 0.87 (MeOH), 0.28 (H2O), 0.88 (DCM);
α-GlucI (mmol ACAE/g extract): 4.62 (MeOH), 3.87 (H2O), 2.24 (DCM); LipI
(mg OE/g extract): 25.9 (MeOH), 10.2 (H2O), 65.8 (DCM)
[87]
S. cadmica Turkey
EA/RA (5.3), Lut (0.8), Api (0.5), MeOH/RA
(31.1), Lut (1.2), Hesp (0.9), H2O/RA (20.6),
Lut (1.1), Api (0.6)
α-GlucI (µmol ACE/g extract): 84.42 (EA), 869.21 (MeOH), 609.85(H2O);
α-AmI (µmol ACE/g extract): 47.14 (EA), 102.28 (MeOH), 16.25 (H2O);
[53]
S. elegans Portugal H2O/RA (35.5), CaffRA (17.9), SA B (7.8) α-GlucI (EC50, µg/mL): 36; LipI (% of inhib): 8.2 [27]
S. euphratica var. leiocalycina Turkey H2O, DCM, MeOH/RA (10.3), Lut-O-Glr(1.6)
α-GlucI (mmol ACAE/g extract): 4.30 (MeOH), 6.18 (H2O), 0.39 (DCM);
α-AmI (mmol ACAE/g extract): 0.77 (MeOH), 0.28 (H2O), 0.88 (DCM); LipI
(mg OE/g extract): 43.92 (MeOH), 69.1 (DCM)
[87]
S. greggii Portugal H2O/Lut-7-O-Glc (26.1), Api-C-hex (15.7),RA (10.9) α-GlucI (EC50, µg/mL): 345.3; α-AmI (% of inhib): 6.5; LipI (% of inhib): 14.4 [27]
S. nemorosa Iran n-hex, DMC, MeOH/RA (7.6), CaffA (0.11),Que (0.15) α-GlucI (IC50, µg/ml): 121.8 (n-hex), 113.6 (DCM), 19.0 (MeOH), 17.0 (Acar) [58]
S. officinalis Portugal H2O/Api-O-Glr (48.4), RA (28.3), Scu-O-Glr(13.4) α-GlucI (EC50, µg/mL): 71.2; LipI (% of inhib): 4.6 [27]
S. syriaca Iran n-hex, DMC, MeOH/Rut (9.43), Que (0.15),Api (0.24), FA (0.19), RA (0.63)
α-GlucI (IC50, mg/ml): 7.18 (n-hex), 4.14 (DCM), 2.13 (MeOH), 9.6 (Acar);




MeOH, H2O, DCM/RA (67), Api-O-Glr (2.1),
SA C der (25)
α-GlucI (mmol ACE/g extract): 7.25 (MeOH), 9.14 (H2O), 10.4 (DCM);
α-AmI (mmol ACE/g extract): 0.62 (MeOH), 0.26 (H2O), 0.90 (DCM); LipI
(mg OE/g extract): 47.0 (MeOH), 65.3 (DCM)
[87]
ACE–acarbose equivalent; Acar–acarbose; Api–apigenin; α-AmI–α-amylase inhibition; α-GlucI–α-glucosidase inhibition; CA–carnosic acid; CaffA–caffeic acid; Car–carnosol; Der–derivatives; DCM–
dichloromethane; EA–ethyl acetate; Hesp–hesperidin; Hex–hexoside; FA–ferulic acid; Glc–glucoside; Glr–glucuronide; I–inhibition; LipI–lipase inhibition; Lut–luteolin; MeOH–methanol; ND–not determined;
n-hex–n-hexane; OlA–oleanolic acid; OE–orlistat equivalent; Que–quercetin; RA–rosmarinic acid; Ros–rosmanol; Rut–rutin; SA–salvianolic acid; Scu–scutelarein; UrA–ursolic acid.
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1.2.2. Antidiabetic and Anti-Obesity Properties of Salvia Extracts—In Vivo Methods
In vivo models also support the hypothesis that Salvia phenolic-rich extracts have
anti-obesity and antidiabetic properties (Table 4). Among them, it was demonstrated that
treatment via gastric intubation of high fat diet rats with methanolic extracts of S. triloba
(750 mg/kg body wt) [92], or the dietary supplementation of olive oil-loaded mice with a
methanolic extract of S. officinalis leaves (doses of 500 and 1000 mg/kg) for 14 days [91],
suppressed serum triglyceride increases. Notably, in this latter study, the authors also
attested that carnosic acid (10 mg/kg) significantly inhibited triglyceride elevation in olive
oil-loaded mice [91].
Along the same lines, the chronic intake of an aqueous extract of Salvia libanotica
(450 mg/kg bw in drinking water, for 6 weeks), improved the glycemia profile of rats
fed with a high fat diet, causing a significant decrease in fasting serum glucose (1.7 times
lower than the control), and also prevented high fat-induced dyslipidemia, by a significant
improvement in serum HDL (1.3-fold that of the control) and the HDL/LDL cholesterol
ratio (about 1.7 times over that of the control), as well as a decrease in abdominal fat [93].
Related to this, the work of Moradabadi and colleagues also underlined the antidiabetic
potential of a methanolic extract of S. officinalis in diabetic rats fed with 500 mg/kg bw
extract for 21 days, significantly reducing postprandial blood glucose in a short-term
period, similar to acarbose (20 mg/kg bw) [94].
In recent years there has been an increasing number of clinical trials aiming to test the
anti-obesity and antidiabetic effects of sage (Table 4). Among them, distinct studies using
S. officinalis L. leaf extracts or tablets, demonstrated that the treatment of patients with
hyperlipidemia and type-2 diabetes afforded a decrease in blood levels of triglycerides,
total cholesterol, LDL cholesterol and postprandial glucose after 2 h, and increased the
levels of HDL cholesterol [39,95–97]. In particular, Behradmanesh et al. [95] reported a
significant decrease in total cholesterol levels and in 2 hours postprandial (2 hpp) glucose
in a randomized clinical trial with 80 patients with type-2 diabetes that received S. officinalis
tablets (150 mg extract, 3 times a day for 3 months). In addition, the treatment of 40 type-2
diabetic patients with S. officinalis leaf extract (one 500 mg capsule for 3 months) was shown
to lower blood levels of fasting glucose, glycosylated hemoglobin (HbA1c), total cholesterol,
triglyceride and LDL, and simultaneously increase the HDL level, compared to the baseline
at endpoint [96]. Moreover, in a randomized double-blind placebo-controlled clinical trial
with 67 hypercholesterolemic and/or hypertriglyceridemic patients, the administration of
sage leaf extract with one 500 mg capsule every 8 h, for 2 months, significantly lowered the
blood levels of total cholesterol, triglyceride, LDL and VLDL (very low density lipoprotein),
and increased the blood HDL levels [97]. Likewise, Sá et al. [98] reported the ability of a
sage tea (S. officinalis) drinking in improving lipid profile, decreasing the total cholesterol
and LDL cholesterol levels and increasing plasma HDL cholesterol levels during and
two weeks after the treatment. These authors also evidenced that sage tea drinking
improved human erythrocyte antioxidant status by significantly increasing SOD and
CAT activities, thus ameliorating antioxidant defenses, which may indirectly improve
the diabetic condition [98]. Overall, the data reported in the above-mentioned studies
suggest that the regular consumption of S. officinalis as tablets or tea can improve the lipid
profile, inducing a decrease in highly atherogenic LDL cholesterol particles (which are
easily oxidable and less readily cleared) and an increase in HDL cholesterol particles—
contributing, therefore, positively to the control of dyslipidemia.
The effect of S. miltiorrhiza in counteracting oxidative stress in aging-associated cardio-
vascular diseases, including diabetes, hyperlipidemia and overweight and obesity has also
been associated with the reduction of ROS production, through the inhibitory activity of
oxidases, reduction in the production of superoxide, inhibition of oxidative modification
of LDL, and amelioration of mitochondrial oxidative stress [99]. In a study performed by
Qian et al. [100], a S. miltiorrhiza hydrophilic extract was demonstrated to reduce oxidative
stress in diabetic patients with chronic heart disease treated with an oral extract of sage
(intake of 5 g extract of S. miltiorrhiza, twice per day for 60). Patients treated with extract of
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S. miltiorrhiza showed a significant decrease in serum MDA level at day 30, while serum
GSH level, SOD, and glutathione reductase (GSSG-R) activities increased markedly at day
60, in comparison to the placebo group (received only hypoglycemic therapy) [100]. Note
that the treatment with S. miltiorrhiza for 30 and 60 days did not show significant differ-
ences in the circulatory concentration of total cholesterol, triglyceride, LDL cholesterol,
HDL cholesterol, fasting blood glucose, HbA1c and fasting serum insulin compared with
baseline and placebo [100]. On the other hand, a double-blind, randomized, controlled trial
including 77 overweight or obese patients with type-2 diabetes, allowed the conclusion
that individuals who received a calorie-restricted diet based on Salvia hispanica L. seeds
(30 g/1000 kcal of ground) lost body weight (6.3-fold that of the controls) and presented
with a reduction in waist circumference (3.2-fold that of the controls). As the patients
submitted to the restricted diet also exibited an increase in adiponectin secretion (7.7 to
8.2 µg/ml, at baseline and after 6-months diet, respectively), the authors associated this
effect to a reduction in visceral obesity [101].
Note that some of the reported clinical studies assured the safety of S. officinalis extracts
through the absence of hepatotoxicity or other adverse effects, such as changes in blood
pressure, heart rate at rest and body weight [95,96,98]. Likewise, no significant changes
in body weight, body mass index and blood pressure, were registered in diabetic patients
after oral consumption of S. miltiorrhiza extract [100].
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Table 4. Antidiabetic and anti-obesity properties of phenolic-enriched extracts of distinct Salvia species—In vivo and clinical experiments.
Salvia Species Origin Solvent Extraction/(MajorComponents) Results of Screen Assay Ref.
S. hispanica L Commercial Grounded plant seed (orally)
Clinical trial: 77 overweight or obese patients with type 2 diabetes
↓body weight:
1.9 ± 0.5 kg, 0.3 ± 0.4 kg (control); ↓ waist circumference: 3.5 ± 0.7 cm and 1.1 ± 0.7 cm
(control); ↑adiponectin: 6.5 ± 0.7%, no changes in control group
[101]
S. libanotica Lebanon H2O–infusion (ND)
Rats fed a high fat diet: ↓fasting serum glucose: 102.9 ± 10.8 (150 mg/Kg bw), 87.5 ± 6.4
(450 mg/Kg bw), 152.1 ± 7.9 mg/dl (control)
↑fasting serum insulin: 87.5 ± 6.4 (450 mg/Kg bw), 152.1 ± 7.9 mg/dl (control); ↑liver
glycogen content: ~2 fold (450 mg/Kg bw, comparing to control); ↑serum HDL: 34.4 ± 2.4
(450 mg/Kg bw), 27.2 ± 1.9 mg/dl (control); ↑HDL/LDL: 2.79 ± 0.32 (150 mg/Kg bw),
3.02 ± 0.31 (450 mg/Kg bw), 1.74 ± 0.18 (control); ↓abdominal fat (% body weight): 0.57 ±
0.06 (450 mg/Kg bw), 0.78 ± 0.08 (control)
[93]
S. miltiorrhiza China H2O (Root) (Danshensu, PrcA, PrcAAld, RA, SA A, SA B)
Clinical trial: 31 diabetic patients with chronic heart disease received sage extract (5 g, twice
per day for 60 days)
Oxidative stress restoration: ↓MDA (nmol/L) at day 30, ↑ GSH (mmol/L), SOD (U/mL),
and GSSG-R (nmol/ml) at day 60, compared with baseline and placebo group (only
hypoglycemic therapy), p < 0.05
[100]
S. officinalis MeOH (CA, Car)
In vitro: LipI (IC50): 94 µg/ml (MeOH), 12 µg/ml (CA, 36 µM), 4.4 µg/ml (Car, 13 µM), 1.5
ng/ml (orlistat, 3.0 nM); ↑Serum TGA (CA (116 mg/100 ml at 5 mg/kg/day for 14 days);
In vivo; ↑body weight (CA (20 mg/kg/day for 14 days)); ↑weight of epidydimal fat pad
(CA, 5–20 mg/kg/day)
[91]
S. officinalis Commercial Sage tablets (150 mg of extract)
Clinical trial: 80 patients with type-2 diabetes received drug (150 mg extract)
BS2hpp (mg/dl): time 0–222.0 (sage), 214.6 (placebo); 12th week – 174.5 (sage), 207.7
(placebo); FBG (mg/dl): time 0–144.2 (sage), 142.9 (placebo); 12th week – 115.0 (sage), 143.4
(placebo); TGA (mg/dl): Before Int – 175.1 (sage), 168.5 (placebo); After Int – 180.4 (sage),
149.7 (placebo); TC (mg/dl): Before Int – 192.4 (sage), 190.7 (placebo); After Int – 101 (sage),
181.62 (placebo); LDL (mg/dl): Before Int – 110.4 (sage), 105.3 (placebo); After Int – 101.6
(sage), 102.91 (placebo); HDL (mg/dl): Before Int – 41.4 (sage), 43.3 (placebo); After Int –
42.2 (sage), 44.02 (placebo)
[95]
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Table 4. Cont.
Salvia Species Origin Solvent Extraction/(MajorComponents) Results of Screen Assay Ref.
S. officinalis Iran
80% MeOH-H2O
Sage capsules (500 mg of the extract
powder)
Clinical trial: 40 patients with type-2 diabetes
% change mean (extract group) compared to baseline: FBG ↓ 25.8, HbA1c ↓ 14.4, TC ↓ 17.7,
TGA ↓ 32.2, LDL ↓ 19.2, HDL ↑ 34.8; % difference between the extract and placebo groups:




Sage capsules (500 mg of the extract
powder)
Clinical trial: 67 hypercholesterolemic and/or hypertriglyceridemic patients
TC (mg/dl): Before Int – 266.3 (sage), 256.8 (placebo); After Int – 211.3 (sage), 261.8
(placebo); TGA (mg/dl): Before Int – 296.7 (sage), 279.1 (placebo); After Int – 227.7 (sage),
288.3 (placebo); VLDL (mg/dl): Before Int – 58.2 (sage), 56.8 (placebo); After Int – 47.6 (sage),
58.6 (placebo); LDL (mg/dl): Before Int – 151.8 (sage), 167.1 (placebo); After Int – 117.5
(sage), 154.2 (placebo); HDL (mg/dl): Before Int – 49.2 (sage), 48.7 (placebo); After Int – 57.6
(sage), 47.1 (placebo)
[97]
S. triloba Jordan MeOH (ND)
In vivo: Plasma TGA inhibition after high fat diet rats (mg/dl): 73.2 (MeOH), 68.1 (orlistat),
217.8 (untreated rats)
In vitro: LipI (IC50): 100.8 µg/ml (MeOH), 114 ng/ml (orlistat)
[92]
Ald–aldehyde; BS2hpp–blood sugar 2 hours postprandial glucose; CA–carnosic acid; Car–carnosol; FBG–fasting blood glucose; GSH–glutathione, GSSG-R–glutathione reductase, HbA1c–glycosylated hemoglobin;
HDL–high density lipoprotein; I–inhibition; Int–intervention; LipI–lipase inhibition; LDL–low density lipoprotein; MDA–malondialdehyde; MeOH–methanol; ND–not determined; PrcA–protocatchuic acid;
RA–rosmarinic acid; Ros–rosmanol; Rut–rutin; SA–salvianolic acid; SOD–superoxide dismutase; TC–total cholesterol; TGA–triglycerides; VLDL–very low density lipoprotein, ↓ decrease; ↑ increase.
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2. Conclusions
Salvia species are rich in phytochemicals, which have been described as agents with
extensive biological effects, boosting their potential uses in medical procedures and appli-
cations in food industries. These health-beneficial activities can combat oxidative stress,
protecting against chronic diseases including diabetes, or other related detrimental con-
ditions, such as overweight and obesity. This review underlines the beneficial properties
associated to polar extracts obtained from sage plants, with particular emphasis on their
capacity to fight oxidative stress, either by scavenging species of oxygen and nitrogen
(e.g., •OH, H2O2, NO•), or by restoring antioxidant components such as CAT, SOD, GPx
and GSH—or even protecting DNA from damage—and to fight obesity and/or diabetic
related events.
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